Axsome Therapeutics, Inc. <AXSM.O>: Morgan Stanley raises target price to $251 from $242
AXSM•Related News
Credo schedules conference call on quarterly results
CRDO•
Electrovaya cuts FY2026 normalized revenue outlook to US$70 million-US$73 million
ELVA•
Navan partners with OpenTable to add restaurant discovery, reservations to Navan Edge travel platform
NAVN•
Surf Air Mobility closes $14 million second tranche of senior secured debenture financing
SRFM•
Rekor Systems wins South Carolina DOT 7-year statewide contract worth over $22 million
REKR•